🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
7.35
+0.01 (0.14%)
At close: Nov 19, 2026, 4:00 PM EST
7.41
+0.06 (0.82%)
After-hours: Nov 19, 2026, 7:56 PM EST

Kura Oncology Revenue

Kura Oncology had revenue of $22.84M in the quarter ending September 30, 2026, with 10.07% growth. This brings the company's total for the last twelve months to $79.31M, down -23.76% year-over-year. In the year 2025, Kura Oncology had annual revenue of $67.48M with 25.24% growth. That makes Kura Oncology the 24,535th largest company in the world by revenue and 3,445th in the United States.

Revenue (ttm)
$79.31M
Revenue Growth
-23.76%
P/S Ratio
8.51
Revenue / Employee
$305,054
Employees
260
Market Cap
675.31M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202567.48M13.60M25.24%
Dec 31, 202453.88M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Apnimed108.80M
Janux Therapeutics23.29M
Iambic Therapeutics18.25M
Prime Medicine7.06M
Attovia Therapeutics1.44M
Revenue Rankings